About Amgen
Amgen is a company based in Thousand Oaks (United States) founded in 1980.. The company has 28,000 employees as of December 31, 2024. Amgen has completed 26 acquisitions, including Abgenix, Alantos Pharmaceuticals and Amgen Astellas BioPharma. Amgen offers products and services including Biologic Medicines and Clinical Trials Services. Amgen operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Thousand Oaks, United States
- Employees 28000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amgen Inc.
-
Annual Revenue
$33.23 B18.64as on Dec 31, 2024
-
Net Profit
$4.09 B-39.11as on Dec 31, 2024
-
EBITDA
$13.9 B6.45as on Dec 31, 2024
-
Latest Funding Round
$175.46 M (USD), Post-IPO
Mar 12, 2012
- Investors
-
Employee Count
28000
as on Dec 31, 2024
-
Investments & Acquisitions
Abgenix
& 25 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Amgen
Amgen is a publicly listed company on the NASDAQ with ticker symbol AMGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Amgen
Amgen offers a comprehensive portfolio of products and services, including Biologic Medicines and Clinical Trials Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for serious illnesses through biologic innovations.
Platforms for optimizing and conducting medical trials worldwide.
Unlock access to complete
Unlock access to complete
Software Development Team
208 people
Leadership Team
193 people
Sales and Marketing
82 people
Data Analysis and Operations Team
73 people
Senior Team
66 people
Operations Team
64 people
Product Management Team
55 people
Scientific Team
34 people
Unlock access to complete
Funding Insights of Amgen
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $175.5M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2012 | Amount | Post-IPO - Amgen | Valuation |
investors |
|
| Jan, 2010 | Amount | Grant - Amgen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amgen
Amgen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amgen
Amgen has strategically engaged in corporate development activities, having acquired 26 companies. Notable acquisitions include Abgenix, Alantos Pharmaceuticals and Amgen Astellas BioPharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops precision medicines for cancer using expert partnerships and drug pipelines.
|
2020 | ||||
|
Prostaglandin-degrading enzyme inhibitors are developed for inflammatory bowel disease treatment.
|
2017 | ||||
|
IL-15 monoclonal antibodies for celiac disease therapies are developed.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Amgen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amgen Comparisons
Competitors of Amgen
Amgen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amgen
Frequently Asked Questions about Amgen
When was Amgen founded?
Amgen was founded in 1980 and raised its 1st funding round 30 years after it was founded.
Where is Amgen located?
Amgen is headquartered in Thousand Oaks, United States. It is registered at Thousand Oaks, California, United States.
Who is the current CEO of Amgen?
Robert Bradway is the current CEO of Amgen.
How many employees does Amgen have?
As of Dec 31, 2024, the latest employee count at Amgen is 28,000.
What is the annual revenue of Amgen?
Annual revenue of Amgen is $33.23B as on Dec 31, 2024.
What does Amgen do?
Amgen was founded in 1980 in Thousand Oaks, United States, within the biotechnology sector. Pharmaceutical products are developed to address multiple diseases through advances in cellular and molecular biology. Human therapeutics are manufactured and marketed, with operations centered on hematology, oncology, and inflammation. In 2022, annual revenues of 26.32 billion were achieved, alongside a net profit of 6.55 billion.
Who are the top competitors of Amgen?
Amgen's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Amgen offer?
Amgen offers Biologic Medicines and Clinical Trials Services.
Is Amgen publicly traded?
Yes, Amgen is publicly traded on NASDAQ under the ticker symbol AMGN.
How many acquisitions has Amgen made?
Amgen has made 26 acquisitions, including Abgenix, Alantos Pharmaceuticals, and Amgen Astellas BioPharma.
Who are Amgen's investors?
Amgen has 1 investor. Key investors include European Union.
What is Amgen's ticker symbol?
The ticker symbol of Amgen is AMGN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.